Digestive System Toxicities of Immune Checkpoint Inhibitors: Mechanisms and Clinical Implications
Immune checkpoint inhibitors (ICIs) have achieved remarkable efficacy in treating malignancies but may simultaneously induce immune-related adverse events (irAEs), among which ICI-related digestive system adverse events (ir-DSAEs) occur with relatively high frequency and present severe clinical mani...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Compuscript Ltd
2026-01-01
|
| Saila: | BIO Integration |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.scienceopen.com/hosted-document?doi=10.15212/bioi-2025-0169 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|